Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 5,668,915 $ 8,224,508
Prepaid expenses and other current assets 3,287,599 2,976,583
Total Current Assets 8,956,514 11,201,091
Intangible assets, net 1,867,162 1,948,913
In-process research and development 12,530,106 12,575,780
Goodwill 36,323,533 36,987,886
Total Assets 59,677,315 62,713,670
Current Liabilities:    
Accounts payable 1,039,068 586,611
Accrued expenses 2,627,461 1,964,580
Accrued expenses - related parties 37,640 18,370
Loans payable - current portion 1,296,466 1,828,079
Loans payable - related parties 86,034 81,277
Derivative liabilities 9,990,253 15,220,367
Total Current Liabilities 15,076,922 19,699,284
Accrued issuable equity 31,080
Loans payable - non current portion 43,607 48,165
Deferred tax liability 3,621,194 3,643,526
Total Liabilities 18,772,803 23,390,975
Commitments and contingencies (Note 8)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class C and Class K preferred stock)
Class C Preferred Stock; 1 share authorized, issued and outstanding at March 31, 2022 and December 31, 2021
Class K Preferred Stock; 1 share authorized, issued and outstanding at March 31, 2022 and December 31, 2021
Common stock, $0.0001 par value; 100,000,000 shares authorized; 34,087,244 and 34,035,925 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 3,409 3,404
Additional paid-in capital 107,930,317 107,184,137
Accumulated other comprehensive income 89,359 817,440
Accumulated deficit (67,118,573) (68,682,286)
Total Stockholders’ Equity 40,904,512 39,322,695
Total Liabilities and Stockholders’ Equity $ 59,677,315 $ 62,713,670